As shown in Fig. 7B, genes in the CXCL10 low-expression group were mainly enriched in metabolic pathways, such as nitrogen metabolism, maturity onset diabetes, and glycosylphosphatidylinositol. The gene discussed is CXCL10; the disease is type 2 diabetes mellitus.